drugset / Trial / NCT01940393

Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria

NCT01940393

Phase 4 Completed 150 enrolled Grupo de Alergología Clínica y Experimental
RandomizedParallel-groupTriple-blindTreatment

Summary

The antihistamines with inhaled steroids are the cornerstone on the symptomatic therapy in the management of patients with rhinitis and the first line of treatment in patients with urticaria. Currently, the use of antihistamines has become popular due to its excellent safety profile and clinical efficacy, however to the investigators knowledge, there are no studies about the pharmacokinetic and pharmacodynamic effects of these drugs in patients of tropical Latin America. The investigators main interest is to evaluate if skin test inhibition correlates with the clinical effect of five anti-histamines.

Timeline

Start
2013-08
Primary completion
2013-12
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bilastine Small molecule Oral
Comparator Cetirizine Other / unclassified Oral
Comparator Desloratadine Small molecule Oral
Comparator Ebastine Small molecule Oral
Comparator Fexofenadine Unknown Oral

Indications